Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

Aurisco Pharma Expands Yangzhou CRDMO Facility for Generic GLP-1 Peptides

Jiuzhou Pharma Earmarks $42 Million for New CDMO Site in Japan

WuXi Biologics’ Novel Bioprocessing Platform Offers Higher Yields, Lower Costs

PackGene and Kudo Bio Partner to Provide End-to-End mRNA Services

Tigermed Expands Footprint and Services by Acquiring Marti Farm, a Croatian CRO

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital